Higgins D - Search Results

1

Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.

Pyles RB, Higgins D, Chalk C, Zalar A, Eiden J, Brown C, Van Nest G, Stanberry LR. Pyles RB, et al. Among authors: higgins d. J Virol. 2002 Nov;76(22):11387-96. doi: 10.1128/jvi.76.22.11387-11396.2002. J Virol. 2002. PMID: 12388699 Free PMC article.

2

Modulation of immunogenicity and allergenicity by controlling the number of immunostimulatory oligonucleotides linked to Amb a 1.

Higgins D, Rodriguez R, Milley R, Marshall J, Abbate C, dela Cruz T, Patton K, Walker F, Chichester K, Eiden J, Tuck S, Van Nest G. Higgins D, et al. J Allergy Clin Immunol. 2006 Aug;118(2):504-10. doi: 10.1016/j.jaci.2006.05.001. Epub 2006 Jun 27. J Allergy Clin Immunol. 2006. PMID: 16890778

3

Immunostimulatory DNA as a vaccine adjuvant.

Higgins D, Marshall JD, Traquina P, Van Nest G, Livingston BD. Higgins D, et al. Expert Rev Vaccines. 2007 Oct;6(5):747-59. doi: 10.1586/14760584.6.5.747. Expert Rev Vaccines. 2007. PMID: 17931155 Free article. Review.

4

Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity.

Andrews CD, Huh MS, Patton K, Higgins D, Van Nest G, Ott G, Lee KD. Andrews CD, et al. Among authors: higgins d. Mol Pharm. 2012 May 7;9(5):1118-25. doi: 10.1021/mp2003835. Epub 2012 Apr 6. Mol Pharm. 2012. PMID: 22376145 Free PMC article.

5

Evolving strategies for the prevention of influenza infection: potential for multistrain targeting.

Livingston BD, Higgins D, Van Nest G. Livingston BD, et al. Among authors: higgins d. BioDrugs. 2006;20(6):335-40. doi: 10.2165/00063030-200620060-00003. BioDrugs. 2006. PMID: 17176120

6

MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice.

Higgins DA, Carlson JR, Van Nest G. Higgins DA, et al. Vaccine. 1996 Apr;14(6):478-84. doi: 10.1016/0264-410x(95)00240-2. Vaccine. 1996. PMID: 8782343

7

Dendritic cells internalize vaccine adjuvant after intramuscular injection.

Dupuis M, Murphy TJ, Higgins D, Ugozzoli M, van Nest G, Ott G, McDonald DM. Dupuis M, et al. Among authors: higgins d. Cell Immunol. 1998 May 25;186(1):18-27. doi: 10.1006/cimm.1998.1283. Cell Immunol. 1998. PMID: 9637761

8

Polymyxin B enhances ISS-mediated immune responses across multiple species.

Marshall JD, Higgins D, Abbate C, Yee P, Teshima G, Ott G, dela Cruz T, Passmore D, Fearon KL, Tuck S, Van Nest G. Marshall JD, et al. Among authors: higgins d. Cell Immunol. 2004 Jun;229(2):93-105. doi: 10.1016/j.cellimm.2004.04.009. Cell Immunol. 2004. PMID: 15474524

9

Autocorrelation and Multifractal Detrended Fluctuation Analyses Reveal Superdiffusive Mass Transport in Solvent-Filled Nanoporous Media.

Olawale LO, Shafiee O, Higgins DA, Ghanbarian B. Olawale LO, et al. Among authors: higgins da. Anal Chem. 2025 Jan 4. doi: 10.1021/acs.analchem.4c03911. Online ahead of print. Anal Chem. 2025. PMID: 39754629

10

Koala MHCII association with chlamydia infertility remains equivocal: a need for new research approaches.

Kidd A, Casteriano A, Krockenberger MB, Higgins DP, Wright BR. Kidd A, et al. Among authors: higgins dp. Sci Rep. 2024 Dec 28;14(1):31074. doi: 10.1038/s41598-024-82217-w. Sci Rep. 2024. PMID: 39730801 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,299 results

Search Page

Filters